<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02486302</url>
  </required_header>
  <id_info>
    <org_study_id>B1801385</org_study_id>
    <secondary_id>ADEQUATE</secondary_id>
    <nct_id>NCT02486302</nct_id>
  </id_info>
  <brief_title>A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.</brief_title>
  <acronym>ADEQUATE</acronym>
  <official_title>A Prospective, Multicenter Non-interventional Study To Evaluate The Efficacy Of Enbrel (Registered) (Etanercept) Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis With Particular Focus On The Clinical Status Improvements Still Observable After 12 Weeks Of Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pfizer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this non-interventional study is to evaluate the efficacy of etanercept during
      routine clinical use over a maximum of 12 months in patients with rheumatoid arthritis,
      psoriatic arthritis, axial spondyloarthritis, or plaque psoriasis. In so doing, particular
      attention will be paid to the proportion of those patients who only attain the desired
      treatment goal after 12 weeks of treatment. The primary efficacy end point for the study is
      the proportion of patients who attain the desired treatment goal after 12 and 24 weeks,
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 24, 2015</start_date>
  <completion_date type="Actual">December 11, 2017</completion_date>
  <primary_completion_date type="Actual">December 11, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Psoriasis Arthritis: Percentage of patients who have either a disease activity score based on 28-joints count (DAS28) &lt;2.6 or meet Minimal Disease Activity (MDA) criteria</measure>
    <time_frame>Week 12</time_frame>
    <description>Change from Baseline in Disease Activity Score Based on 28-joints Count (DAS28) or Minimal Disease activity (MDA), i.e. Patient meets 5 of 7 of the following criteria:
Tender Joint Count=&lt;1
Swollen Joint Count =&lt;1
Psoriasis Area and Severity Index =&lt; 1 or Body surface area =&lt; 3
Patient pain on visual analog scale =&lt; 15
Patient global activity measured on visual analog scale =&lt; 20
Health Assessement Questionnaire (HAQ) =&lt; 0.5
Tender Enthesial Points =&lt; 1</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Axial Spondyloarthritis: Percentage of Patients with Ankylosing Spondylitis Disease Activity Score (ASDAS) &lt; 1.3</measure>
    <time_frame>Week 12</time_frame>
    <description>Ankylosing Spondylitis Disease Activity Score (ASDAS) is a score combining the assessment of back pain, peripheral pain/swelling, duration of morning stiffness, patient global assessment of disease activity (all assessed on a visual analogue scale [0-10cm] or a numerical rating scale [0-10]) and C-Reactive Protein (milligrams per liter [mg/l]) with ASDAS scores ranging from 0 to 10. ASDAS &lt;1.3 = inactive disease, ASDAS 1.3-2.0 = moderate, ASDAS 2.1-3.4 = high and ASDAS &gt;= 3.5 = very high disease activity.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rheumatoid Arthritis: Percentage of patients with Disease Activity Score Based on 28-joints Count (DAS28)&lt;2.6</measure>
    <time_frame>Week 12</time_frame>
    <description>DAS28 calculated from the number of swollen joints (SJC) and painful joints (PJC) using the 28 joints count, the erythrocyte sedimentation rate (ESR) (millimeters per hour [mm/hour]) and patient's global assessment (PGA) of disease activity (participant rated arthritis activity assessment with transformed scores ranging 0 to 10; higher scores indicated greater affectation due to disease activity). DAS28 ≤3.2 = low disease activity, DAS28 &gt;3.2 to 5.1 = moderate to high disease activity.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plaque Psoriasis: Percentage of patients achieving a 75% Improvement in Psoriasis Area and Severity Index (PASI75) Score or a Physician's Global Assessment of &quot;clear&quot; or &quot;almost clear&quot; or a Dermatology Life Quality Index (DLQI) Total Score of 0 or 1</measure>
    <time_frame>Week 12</time_frame>
    <description>The Psoriasis Area and Severity Index (PASI) ranges from 0(no disease)-72(maximal disease). The Body is divided into 4 sections; each area scored by itself and scores combined for final PASI. For each section percent area of skin involved (0=0%] - 6=90-100% and severity (ranged 0-4: 0=none, 1=slight, 2=moderate, 3=marked, 4=very marked) are estimated. Final PASI=sum of severity parameters for each section*area score*weighing factor(head=0.1, upper limbs=0.2, trunk=0.3, lower limbs=0.4). PGA is an average assessment of all psoriatic lesions based on erythema, scale, and Induration. DLQI is the dermatology-specific quality of life measure used for psoriatic population. The 10-item questionnaire has a score range of 0 to 30 with higher scores indicating poor quality of life. An estimate of the minimal clinically important difference of the DLQI total score is a 5 point improvement. Total score range: 0 (best) to 30 (worst).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rheumatoid Arthritis: Percentage of patients with Disease Activity Score Based on 28-joints Count (DAS28)&lt;2.6</measure>
    <time_frame>Week 24</time_frame>
    <description>DAS28 calculated from the number of swollen joints (SJC) and painful joints (PJC) using the 28 joints count, the erythrocyte sedimentation rate (ESR) (millimeters per hour [mm/hour]) and patient's global assessment (PGA) of disease activity (participant rated arthritis activity assessment with transformed scores ranging 0 to 10; higher scores indicated greater affectation due to disease activity). DAS28 ≤3.2 = low disease activity, DAS28 &gt;3.2 to 5.1 = moderate to high disease activity.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rheumatoid Arthritis: Percentage of patients with Disease Activity Score Based on 28-joints Count (DAS28)&lt;2.6</measure>
    <time_frame>Week 52</time_frame>
    <description>DAS28 calculated from the number of swollen joints (SJC) and painful joints (PJC) using the 28 joints count, the erythrocyte sedimentation rate (ESR) (millimeters per hour [mm/hour]) and patient's global assessment (PGA) of disease activity (participant rated arthritis activity assessment with transformed scores ranging 0 to 10; higher scores indicated greater affectation due to disease activity). DAS28 ≤3.2 = low disease activity, DAS28 &gt;3.2 to 5.1 = moderate to high disease activity.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Psoriasis Arthritis: Percentage of patients who have either a disease activity score based on 28-joints count (DAS28) &lt;2.6 or meet Minimal Disease Activity (MDA) criteria</measure>
    <time_frame>Week 24</time_frame>
    <description>Change from Baseline in Disease Activity Score Based on 28-joints Count (DAS28) or Minimal Disease activity (MDA), i.e. Patient meets 5 of 7 of the following criteria: 1)Tender Joint Count=&lt;1 2) Swollen Joint Count =&lt;1 3) Psoriasis Area and Severity Index =&lt; 1 or Body surface area =&lt; 3 4) Patient pain on visual analog scale =&lt; 15 5) Patient global activity measured on visual analog scale =&lt; 20 6) Health Assessement Questionnaire (HAQ) =&lt; 0.5 7) Tender Enthesial Points =&lt; 1</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Axial Spondyloarthritis: Percentage of Patients with Ankylosing Spondylitis Disease Activity Score (ASDAS) &lt; 1.3</measure>
    <time_frame>Week 24</time_frame>
    <description>Ankylosing Spondylitis Disease Activity Score (ASDAS) is a score combining the assessment of back pain, peripheral pain/swelling, duration of morning stiffness, patient global assessment of disease activity (all assessed on a visual analogue scale [0-10cm] or a numerical rating scale [0-10]) and C-Reactive Protein (milligrams per liter [mg/l]) with ASDAS scores ranging from 0 to 10. ASDAS &lt;1.3 = inactive disease, ASDAS 1.3-2.0 = moderate, ASDAS 2.1-3.4 = high and ASDAS &gt;= 3.5 = very high disease activity.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plaque Psoriasis: Percentage of patients achieving a 75% Improvement in Psoriasis Area and Severity Index (PASI75) Score or a Physician's Global Assessment of &quot;clear&quot; or &quot;almost clear&quot; or a Dermatology Life Quality Index (DLQI) Total Score of 0 or 1</measure>
    <time_frame>Week 24</time_frame>
    <description>The Psoriasis Area and Severity Index (PASI) ranges from 0(no disease)-72(maximal disease). The Body is divided into 4 sections; each area scored by itself and scores combined for final PASI. For each section percent area of skin involved (0=0%] - 6=90-100% and severity (ranged 0-4: 0=none, 1=slight, 2=moderate, 3=marked, 4=very marked) are estimated. Final PASI=sum of severity parameters for each section*area score*weighing factor(head=0.1, upper limbs=0.2, trunk=0.3, lower limbs=0.4). PGA is an average assessment of all psoriatic lesions based on erythema, scale, and Induration. DLQI is the dermatology-specific quality of life measure used for psoriatic population. The 10-item questionnaire has a score range of 0 to 30 with higher scores indicating poor quality of life. An estimate of the minimal clinically important difference of the DLQI total score is a 5 point improvement. Total score range: 0 (best) to 30 (worst).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients who continue treatment with etanercept</measure>
    <time_frame>Week 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient global assessment of disease activity</measure>
    <time_frame>Week 12</time_frame>
    <description>Participant rated Instrument to measure particpant's global assessment of disease activity on a 10 cm visual analogue scale, ranging from no activity to highest possible activity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physician Global Assessment of Disease Activity</measure>
    <time_frame>Week 12</time_frame>
    <description>Physciain Global Assessment of Disease Activity on a 10cm visual analogue scale ranging from no activity to highest possible activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient assessment of Fatigue</measure>
    <time_frame>Week 12</time_frame>
    <description>Patient assessment of Fatigue measured on a 10cm visual analogue scale ranging from &quot;not at all&quot; to &quot;greatly fatigued&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Assessment of Pain</measure>
    <time_frame>Week 12</time_frame>
    <description>Patient assessment of pain measured on a 10cm visual analogue scale ranging from &quot;no pain&quot; to &quot;very severe pain&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Health Questionnaire-2</measure>
    <time_frame>Week 12</time_frame>
    <description>The Patient Health Questionnaire-2 (PHQ-2) is a Brief Depression Screening Instrument. It inquires about the frequency of depressed mood and anhedonia over the past 2 weeks, scoring each as 0 (&quot;not at all&quot;) to 3 (&quot;nearly every day&quot;). It ranges from 0-6.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rheumatoid Arthritis, axial Spondyloarthritis, Psoriasis Arthritis: Hannover functional status questionnaire (FFbH) Score</measure>
    <time_frame>Week 12</time_frame>
    <description>The Hannover Functional Status Questionnaire (Funktionsfragebogen Hannover, FFbH) measures limitations in activities of daily living. Scores are given in percent of full function (range 0 to 100).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rheumatoid Arthritis: Clinical Disease Activity Index (CDAI)</measure>
    <time_frame>Week 12</time_frame>
    <description>The CDAI is the numerical sum of 4 outcome parameters: tender joint count (TJC) and swollen joint count (SJC) based on a 28-joint assessment, patient global assessment (PtGA) and physician global assessment (PGA) assessed on 0-10 cm VAS; higher scores=greater affection due to disease activity. CDAI total score = 0-76. CDAI &lt;= 2.8 indicates disease remission, &gt;2.8 to 10 = low disease activity, &gt;10 to 22 = moderate disease activity, and &gt;22 = high disease activity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rheumatoid Arthritis: Simplified Disease Activity Index (SDAI)</measure>
    <time_frame>Week 12</time_frame>
    <description>The SDAI is the numerical sum of five outcome parameters: tender joint count (TJC) and swollen joint count (SJC) based on a 28-joint assessment, patient global assessment (PtGA) and physician global assessment (PGA) assessed on 0-10 cm VAS; higher scores=greater affection due to disease activity, and C-reactive protein (CRP) (mg/dL). SDAI total score= 0-86. SDAI &lt;=3.3 indicates disease remission, &gt;3.4 to 11 = low disease activity, &gt;11 to 26 = moderate disease activity, and &gt;26 = high disease activity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plaque Psoriasis: Body Surface Area (BSA)</measure>
    <time_frame>Week 12</time_frame>
    <description>Percentage of the Body surface affected by lesions, range 0-100%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Axial Spondyloarthritis: Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)</measure>
    <time_frame>Week 12</time_frame>
    <description>BASDAI is a validated self assessment tool used to determine disease activity in participant with Ankylosing Spondylitis (AS). Utilizing a Visual Analog Scale (VAS) of 0-10 (0=none and 10=very severe) participant's answered 6 questions measuring discomfort, pain and fatigue. The final BASDAI score averages the individual assessments for a final score range of 0-10.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Axial Spondyloarthritis: Occiput-to-wall distance</measure>
    <time_frame>Baseline, Week 12</time_frame>
    <description>Occiput-to-wall distance: distance between the occiput (posterior or back portion of the head) and the wall when the participant stood with heels and shoulder against the wall and the back straight.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plaque Psoriasis: Dermatology Life Quality Index (DLQI)</measure>
    <time_frame>Week 12</time_frame>
    <description>DLQI is the dermatology-specific quality of life measure used for psoriatic population. The 10-item questionnaire has a score range of 0 to 30 with higher scores indicating poor quality of life. An estimate of the minimal clinically important difference of the DLQI total score is a 5 point improvement. Total score range: 0 (best) to 30 (worst).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Axial Spondyloarthritis, Psoriasis Arthritis: Number of tendons affected by enthesitis</measure>
    <time_frame>Week 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psoriasis Arthritis: Number of fingers or toes affected by Dactylitis</measure>
    <time_frame>Week 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rheumatoid Arthritis: Percentage of patients with Disease Activity Score Based on 28-joints Count (DAS28)&lt;2.6</measure>
    <time_frame>Week 36</time_frame>
    <description>DAS28 calculated from the number of swollen joints (SJC) and painful joints (PJC) using the 28 joints count, the erythrocyte sedimentation rate (ESR) (millimeters per hour [mm/hour]) and patient's global assessment (PGA) of disease activity (participant rated arthritis activity assessment with transformed scores ranging 0 to 10; higher scores indicated greater affectation due to disease activity). DAS28 ≤3.2 = low disease activity, DAS28 &gt;3.2 to 5.1 = moderate to high disease activity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between visual analogue scale measures &quot;patient global assessment&quot;, &quot;fatigue&quot;, &quot;pain&quot;, &quot;physician global assessment&quot; and &quot;Patient Health Questionnaire-2 (PHQ-2)&quot; across all indications</measure>
    <time_frame>Week 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between Hannover functional status questionnaire (FFbH) and duration of morning stiffness</measure>
    <time_frame>Week 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plaque Psoriasis: Patient Assessment of Pruritus</measure>
    <time_frame>Week 12</time_frame>
    <description>Patient Assessment of Pruritus measured on a visual analogue scale ranging from &quot;no Pruritus&quot; to &quot;most severe Pruritus&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Axial Spondyloarthritis: Percentage of Patients with Ankylosing Spondylitis Disease Activity Score (ASDAS) &lt; 1.3</measure>
    <time_frame>Week 36</time_frame>
    <description>Ankylosing Spondylitis Disease Activity Score (ASDAS) is a score combining the assessment of back pain, peripheral pain/swelling, duration of morning stiffness, patient global assessment of disease activity (all assessed on a visual analogue scale [0-10cm] or a numerical rating scale [0-10]) and C-Reactive Protein (milligrams per liter [mg/l]) with ASDAS scores ranging from 0 to 10. ASDAS &lt;1.3 = inactive disease, ASDAS 1.3-2.0 = moderate, ASDAS 2.1-3.4 = high and ASDAS &gt;= 3.5 = very high disease activity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psoriasis Arthritis: Percentage of patients who have either a disease activity score based on 28-joints count (DAS28) &lt;2.6 or meet Minimal Disease Activity (MDA) criteria</measure>
    <time_frame>Week 36</time_frame>
    <description>Change from Baseline in Disease Activity Score Based on 28-joints Count (DAS28) or Minimal Disease activity (MDA), i.e. Patient meets 5 of 7 of the following criteria: 1)Tender Joint Count=&lt;1 2) Swollen Joint Count =&lt;1 3) Psoriasis Area and Severity Index =&lt; 1 or Body surface area =&lt; 3 4) Patient pain on visual analog scale =&lt; 15 5) Patient global activity measured on visual analog scale =&lt; 20 6) Health Assessement Questionnaire (HAQ) =&lt; 0.5 7) Tender Enthesial Points =&lt; 1</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plaque Psoriasis: Percentage of patients achieving a 75% Improvement in Psoriasis Area and Severity Index (PASI75) Score or a Physician's Global Assessment of &quot;clear&quot; or &quot;almost clear&quot; or a Dermatology Life Quality Index (DLQI) Total Score of 0 or 1</measure>
    <time_frame>Week 36</time_frame>
    <description>The Psoriasis Area and Severity Index (PASI) ranges from 0(no disease)-72(maximal disease). The Body is divided into 4 sections; each area scored by itself and scores combined for final PASI. For each section percent area of skin involved (0=0%] - 6=90-100% and severity (ranged 0-4: 0=none, 1=slight, 2=moderate, 3=marked, 4=very marked) are estimated. Final PASI=sum of severity parameters for each section*area score*weighing factor(head=0.1, upper limbs=0.2, trunk=0.3, lower limbs=0.4). PGA is an average assessment of all psoriatic lesions based on erythema, scale, and Induration. DLQI is the dermatology-specific quality of life measure used for psoriatic population. The 10-item questionnaire has a score range of 0 to 30 with higher scores indicating poor quality of life. An estimate of the minimal clinically important difference of the DLQI total score is a 5 point improvement. Total score range: 0 (best) to 30 (worst).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plaque Psoriasis: Change in Psoriasis Area and Severity Index (PASI) Score</measure>
    <time_frame>Baseline, 24 weeks</time_frame>
    <description>Percentage Change in the Psoriasis Area and Severity Index (PASI). PASI ranges from 0(no disease)-72(maximal disease). The Body is divided into 4 sections; each area scored by itself and scores combined for final PASI. For each section percent area of skin involved (0=0%] - 6=90-100% and severity (ranged 0-4: 0=none, 1=slight, 2=moderate, 3=marked, 4=very marked) are estimated. Final PASI=sum of severity parameters for each section*area score*weighing factor(head=0.1, upper limbs=0.2, trunk=0.3, lower limbs=0.4).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plaque Psoriasis: Median time until 75% improvement in Psoriasis Area and Severity Index (PASI75) Score is achieved</measure>
    <time_frame>24 weeks</time_frame>
    <description>Psoriasis Area and Severity Index (PASI) ranges from 0(no disease)-72(maximal disease). The Body is divided into 4 sections; each area scored by itself and scores combined for final PASI. For each section percent area of skin involved (0=0%] - 6=90-100% and severity (ranged 0-4: 0=none, 1=slight, 2=moderate, 3=marked, 4=very marked) are estimated. Final PASI=sum of severity parameters for each section*area score*weighing factor(head=0.1, upper limbs=0.2, trunk=0.3, lower limbs=0.4).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients who continue treatment with etanercept</measure>
    <time_frame>Week 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients who continue treatment with etanercept</measure>
    <time_frame>Week 36</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients who continue treatment with etanercept</measure>
    <time_frame>Week 52</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Adverse Events and Serious Adverse Events per Participant-Year</measure>
    <time_frame>Week 24</time_frame>
    <description>Participant-Year estimated by calculating all of the years that participants in a study were followed (mean study drug exposure duration multiplied by safety set population). Incidence calculated as AEs or SAEs divided by Participant-Year multiplied by 100.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Adverse Events and Serious Adverse Events per Participant-Year</measure>
    <time_frame>Week 36</time_frame>
    <description>Participant-Year estimated by calculating all of the years that participants in a study were followed (mean study drug exposure duration multiplied by safety set population). Incidence calculated as AEs or SAEs divided by Participant-Year multiplied by 100.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Adverse Events and Serious Adverse Events per Participant-Year</measure>
    <time_frame>Week 52</time_frame>
    <description>Participant-Year estimated by calculating all of the years that participants in a study were followed (mean study drug exposure duration multiplied by safety set population). Incidence calculated as AEs or SAEs divided by Participant-Year multiplied by 100.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient global assessment of disease activity</measure>
    <time_frame>Week 24</time_frame>
    <description>Participant rated Instrument to measure particpant's global assessment of disease activity on a 10 cm visual analogue scale, ranging from no activity to highest possible activity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient global assessment of disease activity</measure>
    <time_frame>Week 36</time_frame>
    <description>Participant rated Instrument to measure particpant's global assessment of disease activity on a 10 cm visual analogue scale, ranging from no activity to highest possible activity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient global assessment of disease activity</measure>
    <time_frame>Week 52</time_frame>
    <description>Participant rated Instrument to measure particpant's global assessment of disease activity on a 10 cm visual analogue scale, ranging from no activity to highest possible activity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physician Global Assessment of Disease Activity</measure>
    <time_frame>Week 24</time_frame>
    <description>Physciain Global Assessment of Disease Activity on a 10cm visual analogue scale ranging from no activity to highest possible activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physician Global Assessment of Disease Activity</measure>
    <time_frame>Week 36</time_frame>
    <description>Physciain Global Assessment of Disease Activity on a 10cm visual analogue scale ranging from no activity to highest possible activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physician Global Assessment of Disease Activity</measure>
    <time_frame>Week 52</time_frame>
    <description>Physciain Global Assessment of Disease Activity on a 10cm visual analogue scale ranging from no activity to highest possible activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient assessment of Fatigue</measure>
    <time_frame>Week 24</time_frame>
    <description>Patient assessment of Fatigue measured on a 10cm visual analogue scale ranging from &quot;not at all&quot; to &quot;greatly fatigued&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient assessment of Fatigue</measure>
    <time_frame>Week 36</time_frame>
    <description>Patient assessment of Fatigue measured on a 10cm visual analogue scale ranging from &quot;not at all&quot; to &quot;greatly fatigued&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient assessment of Fatigue</measure>
    <time_frame>Week 52</time_frame>
    <description>Patient assessment of Fatigue measured on a 10cm visual analogue scale ranging from &quot;not at all&quot; to &quot;greatly fatigued&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Assessment of Pain</measure>
    <time_frame>Week 24</time_frame>
    <description>Patient assessment of pain measured on a 10cm visual analogue scale ranging from &quot;no pain&quot; to &quot;very severe pain&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Assessment of Pain</measure>
    <time_frame>Week 36</time_frame>
    <description>Patient assessment of pain measured on a 10cm visual analogue scale ranging from &quot;no pain&quot; to &quot;very severe pain&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Assessment of Pain</measure>
    <time_frame>Week 52</time_frame>
    <description>Patient assessment of pain measured on a 10cm visual analogue scale ranging from &quot;no pain&quot; to &quot;very severe pain&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Health Questionnaire-2</measure>
    <time_frame>Week 24</time_frame>
    <description>The Patient Health Questionnaire-2 (PHQ-2) is a Brief Depression Screening Instrument. It inquires about the frequency of depressed mood and anhedonia over the past 2 weeks, scoring each as 0 (&quot;not at all&quot;) to 3 (&quot;nearly every day&quot;). It ranges from 0-6.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Health Questionnaire-2</measure>
    <time_frame>Week 36</time_frame>
    <description>The Patient Health Questionnaire-2 (PHQ-2) is a Brief Depression Screening Instrument. It inquires about the frequency of depressed mood and anhedonia over the past 2 weeks, scoring each as 0 (&quot;not at all&quot;) to 3 (&quot;nearly every day&quot;). It ranges from 0-6.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Health Questionnaire-2</measure>
    <time_frame>Week 52</time_frame>
    <description>The Patient Health Questionnaire-2 (PHQ-2) is a Brief Depression Screening Instrument. It inquires about the frequency of depressed mood and anhedonia over the past 2 weeks, scoring each as 0 (&quot;not at all&quot;) to 3 (&quot;nearly every day&quot;). It ranges from 0-6.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rheumatoid Arthritis, axial Spondyloarthritis, Psoriasis Arthritis: Hannover functional status questionnaire (FFbH) Score</measure>
    <time_frame>Week 24</time_frame>
    <description>The Hannover Functional Status Questionnaire (Funktionsfragebogen Hannover, FFbH) measures limitations in activities of daily living. Scores are given in percent of full function (range 0 to 100).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rheumatoid Arthritis, axial Spondyloarthritis, Psoriasis Arthritis: Hannover functional status questionnaire (FFbH) Score</measure>
    <time_frame>Week 36</time_frame>
    <description>The Hannover Functional Status Questionnaire (Funktionsfragebogen Hannover, FFbH) measures limitations in activities of daily living. Scores are given in percent of full function (range 0 to 100).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rheumatoid Arthritis, axial Spondyloarthritis, Psoriasis Arthritis: Hannover functional status questionnaire (FFbH) Score</measure>
    <time_frame>Week 52</time_frame>
    <description>The Hannover Functional Status Questionnaire (Funktionsfragebogen Hannover, FFbH) measures limitations in activities of daily living. Scores are given in percent of full function (range 0 to 100).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rheumatoid Arthritis: Clinical Disease Activity Index (CDAI)</measure>
    <time_frame>Week 24</time_frame>
    <description>The CDAI is the numerical sum of 4 outcome parameters: tender joint count (TJC) and swollen joint count (SJC) based on a 28-joint assessment, patient global assessment (PtGA) and physician global assessment (PGA) assessed on 0-10 cm VAS; higher scores=greater affection due to disease activity. CDAI total score = 0-76. CDAI &lt;= 2.8 indicates disease remission, &gt;2.8 to 10 = low disease activity, &gt;10 to 22 = moderate disease activity, and &gt;22 = high disease activity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rheumatoid Arthritis: Clinical Disease Activity Index (CDAI)</measure>
    <time_frame>Week 36</time_frame>
    <description>The CDAI is the numerical sum of 4 outcome parameters: tender joint count (TJC) and swollen joint count (SJC) based on a 28-joint assessment, patient global assessment (PtGA) and physician global assessment (PGA) assessed on 0-10 cm VAS; higher scores=greater affection due to disease activity. CDAI total score = 0-76. CDAI &lt;= 2.8 indicates disease remission, &gt;2.8 to 10 = low disease activity, &gt;10 to 22 = moderate disease activity, and &gt;22 = high disease activity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rheumatoid Arthritis: Clinical Disease Activity Index (CDAI)</measure>
    <time_frame>Week 52</time_frame>
    <description>The CDAI is the numerical sum of 4 outcome parameters: tender joint count (TJC) and swollen joint count (SJC) based on a 28-joint assessment, patient global assessment (PtGA) and physician global assessment (PGA) assessed on 0-10 cm VAS; higher scores=greater affection due to disease activity. CDAI total score = 0-76. CDAI &lt;= 2.8 indicates disease remission, &gt;2.8 to 10 = low disease activity, &gt;10 to 22 = moderate disease activity, and &gt;22 = high disease activity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rheumatoid Arthritis: Simplified Disease Activity Index (SDAI)</measure>
    <time_frame>Week 24</time_frame>
    <description>The SDAI is the numerical sum of five outcome parameters: tender joint count (TJC) and swollen joint count (SJC) based on a 28-joint assessment, patient global assessment (PtGA) and physician global assessment (PGA) assessed on 0-10 cm VAS; higher scores=greater affection due to disease activity, and C-reactive protein (CRP) (mg/dL). SDAI total score= 0-86. SDAI &lt;=3.3 indicates disease remission, &gt;3.4 to 11 = low disease activity, &gt;11 to 26 = moderate disease activity, and &gt;26 = high disease activity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rheumatoid Arthritis: Simplified Disease Activity Index (SDAI)</measure>
    <time_frame>Week 36</time_frame>
    <description>The SDAI is the numerical sum of five outcome parameters: tender joint count (TJC) and swollen joint count (SJC) based on a 28-joint assessment, patient global assessment (PtGA) and physician global assessment (PGA) assessed on 0-10 cm VAS; higher scores=greater affection due to disease activity, and C-reactive protein (CRP) (mg/dL). SDAI total score= 0-86. SDAI &lt;=3.3 indicates disease remission, &gt;3.4 to 11 = low disease activity, &gt;11 to 26 = moderate disease activity, and &gt;26 = high disease activity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rheumatoid Arthritis: Simplified Disease Activity Index (SDAI)</measure>
    <time_frame>Week 52</time_frame>
    <description>The SDAI is the numerical sum of five outcome parameters: tender joint count (TJC) and swollen joint count (SJC) based on a 28-joint assessment, patient global assessment (PtGA) and physician global assessment (PGA) assessed on 0-10 cm VAS; higher scores=greater affection due to disease activity, and C-reactive protein (CRP) (mg/dL). SDAI total score= 0-86. SDAI &lt;=3.3 indicates disease remission, &gt;3.4 to 11 = low disease activity, &gt;11 to 26 = moderate disease activity, and &gt;26 = high disease activity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plaque Psoriasis: Body Surface Area (BSA)</measure>
    <time_frame>Week 24</time_frame>
    <description>Percentage of the Body surface affected by lesions, range 0-100%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plaque Psoriasis: Body Surface Area (BSA)</measure>
    <time_frame>Week 36</time_frame>
    <description>Percentage of the Body surface affected by lesions, range 0-100%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plaque Psoriasis: Body Surface Area (BSA)</measure>
    <time_frame>Week 52</time_frame>
    <description>Percentage of the Body surface affected by lesions, range 0-100%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Axial Spondyloarthritis: Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)</measure>
    <time_frame>Week 24</time_frame>
    <description>BASDAI is a validated self assessment tool used to determine disease activity in participant with Ankylosing Spondylitis (AS). Utilizing a Visual Analog Scale (VAS) of 0-10 (0=none and 10=very severe) participant's answered 6 questions measuring discomfort, pain and fatigue. The final BASDAI score averages the individual assessments for a final score range of 0-10.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Axial Spondyloarthritis: Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)</measure>
    <time_frame>Week 36</time_frame>
    <description>BASDAI is a validated self assessment tool used to determine disease activity in participant with Ankylosing Spondylitis (AS). Utilizing a Visual Analog Scale (VAS) of 0-10 (0=none and 10=very severe) participant's answered 6 questions measuring discomfort, pain and fatigue. The final BASDAI score averages the individual assessments for a final score range of 0-10.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Axial Spondyloarthritis: Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)</measure>
    <time_frame>Week 52</time_frame>
    <description>BASDAI is a validated self assessment tool used to determine disease activity in participant with Ankylosing Spondylitis (AS). Utilizing a Visual Analog Scale (VAS) of 0-10 (0=none and 10=very severe) participant's answered 6 questions measuring discomfort, pain and fatigue. The final BASDAI score averages the individual assessments for a final score range of 0-10.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Axial Spondyloarthritis: Occiput-to-wall distance</measure>
    <time_frame>Baseline, Week 24</time_frame>
    <description>Occiput-to-wall distance: distance between the occiput (posterior or back portion of the head) and the wall when the participant stood with heels and shoulder against the wall and the back straight.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Axial Spondyloarthritis: Occiput-to-wall distance</measure>
    <time_frame>Baseline, Week 36</time_frame>
    <description>Occiput-to-wall distance: distance between the occiput (posterior or back portion of the head) and the wall when the participant stood with heels and shoulder against the wall and the back straight.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Axial Spondyloarthritis: Occiput-to-wall distance</measure>
    <time_frame>Baseline, Week 52</time_frame>
    <description>Occiput-to-wall distance: distance between the occiput (posterior or back portion of the head) and the wall when the participant stood with heels and shoulder against the wall and the back straight.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plaque Psoriasis: Dermatology Life Quality Index (DLQI)</measure>
    <time_frame>Week 24</time_frame>
    <description>DLQI is the dermatology-specific quality of life measure used for psoriatic population. The 10-item questionnaire has a score range of 0 to 30 with higher scores indicating poor quality of life. An estimate of the minimal clinically important difference of the DLQI total score is a 5 point improvement. Total score range: 0 (best) to 30 (worst).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plaque Psoriasis: Dermatology Life Quality Index (DLQI)</measure>
    <time_frame>Week 36</time_frame>
    <description>DLQI is the dermatology-specific quality of life measure used for psoriatic population. The 10-item questionnaire has a score range of 0 to 30 with higher scores indicating poor quality of life. An estimate of the minimal clinically important difference of the DLQI total score is a 5 point improvement. Total score range: 0 (best) to 30 (worst).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plaque Psoriasis: Dermatology Life Quality Index (DLQI)</measure>
    <time_frame>Week 52</time_frame>
    <description>DLQI is the dermatology-specific quality of life measure used for psoriatic population. The 10-item questionnaire has a score range of 0 to 30 with higher scores indicating poor quality of life. An estimate of the minimal clinically important difference of the DLQI total score is a 5 point improvement. Total score range: 0 (best) to 30 (worst).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Axial Spondyloarthritis, Psoriasis Arthritis: Number of tendons affected by enthesitis</measure>
    <time_frame>Week 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Axial Spondyloarthritis, Psoriasis Arthritis: Number of tendons affected by enthesitis</measure>
    <time_frame>Week 36</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Axial Spondyloarthritis, Psoriasis Arthritis: Number of tendons affected by enthesitis</measure>
    <time_frame>Week 52</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psoriasis Arthritis: Number of fingers or toes affected by Dactylitis</measure>
    <time_frame>Week 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psoriasis Arthritis: Number of fingers or toes affected by Dactylitis</measure>
    <time_frame>Week 36</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psoriasis Arthritis: Number of fingers or toes affected by Dactylitis</measure>
    <time_frame>Week 52</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between visual analogue scale measures &quot;patient global assessment&quot;, &quot;fatigue&quot;, &quot;pain&quot;, &quot;physician global assessment&quot; and &quot;Patient Health Questionnaire-2 (PHQ-2)&quot; across all indications</measure>
    <time_frame>Week 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between visual analogue scale measures &quot;patient global assessment&quot;, &quot;fatigue&quot;, &quot;pain&quot;, &quot;physician global assessment&quot; and &quot;Patient Health Questionnaire-2 (PHQ-2)&quot; across all indications</measure>
    <time_frame>Week 36</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between visual analogue scale measures &quot;patient global assessment&quot;, &quot;fatigue&quot;, &quot;pain&quot;, &quot;physician global assessment&quot; and &quot;Patient Health Questionnaire-2 (PHQ-2)&quot; across all indications</measure>
    <time_frame>Week 52</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between Hannover functional status questionnaire (FFbH) and duration of morning stiffness</measure>
    <time_frame>Week 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between Hannover functional status questionnaire (FFbH) and duration of morning stiffness</measure>
    <time_frame>Week 36</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between Hannover functional status questionnaire (FFbH) and duration of morning stiffness</measure>
    <time_frame>Week 52</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of participants who discontinued treatment due to adverse events</measure>
    <time_frame>Week 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of participants who discontinued treatment due to adverse events</measure>
    <time_frame>Week 36</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of participants who discontinued treatment due to adverse events</measure>
    <time_frame>Week 52</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plaque Psoriasis: Patient Assessment of Pruritus</measure>
    <time_frame>Week 24</time_frame>
    <description>Patient Assessment of Pruritus measured on a visual analogue scale ranging from &quot;no Pruritus&quot; to &quot;most severe Pruritus&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plaque Psoriasis: Patient Assessment of Pruritus</measure>
    <time_frame>Week 36</time_frame>
    <description>Patient Assessment of Pruritus measured on a visual analogue scale ranging from &quot;no Pruritus&quot; to &quot;most severe Pruritus&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plaque Psoriasis: Patient Assessment of Pruritus</measure>
    <time_frame>Week 52</time_frame>
    <description>Patient Assessment of Pruritus measured on a visual analogue scale ranging from &quot;no Pruritus&quot; to &quot;most severe Pruritus&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Axial Spondyloarthritis: Percentage of Patients with Ankylosing Spondylitis Disease Activity Score (ASDAS) &lt; 1.3</measure>
    <time_frame>Week 52</time_frame>
    <description>Ankylosing Spondylitis Disease Activity Score (ASDAS) is a score combining the assessment of back pain, peripheral pain/swelling, duration of morning stiffness, patient global assessment of disease activity (all assessed on a visual analogue scale [0-10cm] or a numerical rating scale [0-10]) and C-Reactive Protein (milligrams per liter [mg/l]) with ASDAS scores ranging from 0 to 10. ASDAS &lt;1.3 = inactive disease, ASDAS 1.3-2.0 = moderate, ASDAS 2.1-3.4 = high and ASDAS &gt;= 3.5 = very high disease activity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psoriasis Arthritis: Percentage of patients who have either a disease activity score based on 28-joints count (DAS28) &lt;2.6 or meet Minimal Disease Activity (MDA) criteria</measure>
    <time_frame>Week 52</time_frame>
    <description>Change from Baseline in Disease Activity Score Based on 28-joints Count (DAS28) or Minimal Disease activity (MDA), i.e. Patient meets 5 of 7 of the following criteria: 1)Tender Joint Count=&lt;1 2) Swollen Joint Count =&lt;1 3) Psoriasis Area and Severity Index =&lt; 1 or Body surface area =&lt; 3 4) Patient pain on visual analog scale =&lt; 15 5) Patient global activity measured on visual analog scale =&lt; 20 6) Health Assessement Questionnaire (HAQ) =&lt; 0.5 7) Tender Enthesial Points =&lt; 1 No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plaque Psoriasis: Percentage of patients achieving a 75% Improvement in Psoriasis Area and Severity Index (PASI75) Score or a Physician's Global Assessment of &quot;clear&quot; or &quot;almost clear&quot; or a Dermatology Life Quality Index (DLQI) Total Score of 0 or 1</measure>
    <time_frame>Week 52</time_frame>
    <description>The Psoriasis Area and Severity Index (PASI) ranges from 0(no disease)-72(maximal disease). The Body is divided into 4 sections; each area scored by itself and scores combined for final PASI. For each section percent area of skin involved (0=0%] - 6=90-100% and severity (ranged 0-4: 0=none, 1=slight, 2=moderate, 3=marked, 4=very marked) are estimated. Final PASI=sum of severity parameters for each section*area score*weighing factor(head=0.1, upper limbs=0.2, trunk=0.3, lower limbs=0.4). PGA is an average assessment of all psoriatic lesions based on erythema, scale, and Induration. DLQI is the dermatology-specific quality of life measure used for psoriatic population. The 10-item questionnaire has a score range of 0 to 30 with higher scores indicating poor quality of life. An estimate of the minimal clinically important difference of the DLQI total score is a 5 point improvement. Total score range: 0 (best) to 30 (worst).</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1535</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Psoriatic Arthritis</condition>
  <condition>Axial Spondyloarthritis</condition>
  <condition>Plaque Psoriasis</condition>
  <arm_group>
    <arm_group_label>Observation Group</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Etanercept</intervention_name>
    <description>Etanercept shall be used according to clinical practice and in line with the summary of product characteristics.</description>
    <arm_group_label>Observation Group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Ambulatory and Hospital care patients treated for Rheumatoid Arthritis, Axial
        Spondyloarthritis, Psoriasis Arthritis or Plaque Psoriasis in Germany
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Confirmed diagnosis of RA, axSpA, PsA or PsO

          -  No prior treatment with etanercept and eligibility for treatment with etanercept
             according to the summary of product characteristics.

        Exclusion Criteria:

          -  The contraindications, special warnings, and precautions according to the summary of
             product characteristics for etanercept shall apply.

          -  The additional documentation of the patient in another post-marketing study with
             etanercept is not permitted.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pfizer CT.gov Call Center</last_name>
    <role>Study Director</role>
    <affiliation>Pfizer</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rheumatologisches MVZ Dresden GmbH im Gesundheitszentrum Dresden - Klotzsche (GZDK)</name>
      <address>
        <city>Dresden</city>
        <state>Sachsen</state>
        <zip>01109</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Hemmerich</name>
      <address>
        <city>Aachen</city>
        <zip>52062</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Kurthen</name>
      <address>
        <city>Aachen</city>
        <zip>52064</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gesundheits- und Pflegezentrum Alsfeld gGmbH</name>
      <address>
        <city>Alsfeld</city>
        <zip>36304</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Kupka</name>
      <address>
        <city>Altenburg</city>
        <zip>4600</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practise Boehm</name>
      <address>
        <city>Altenholz</city>
        <zip>24161</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practise Marycz</name>
      <address>
        <city>Amberg</city>
        <zip>92224</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Bad Bramstedt</name>
      <address>
        <city>Bad Bramstedt</city>
        <zip>24576</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Gause</name>
      <address>
        <city>Bad Bramstedt</city>
        <zip>24576</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Messis</name>
      <address>
        <city>Bad Homburg</city>
        <zip>61348</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ACURA Rheumazentrum Bad Kreuznach</name>
      <address>
        <city>Bad Kreuznach</city>
        <zip>55543</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Hesse</name>
      <address>
        <city>Bad Kreuznach</city>
        <zip>55543</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Manger</name>
      <address>
        <city>Bamberg</city>
        <zip>96047</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Balzer</name>
      <address>
        <city>Bautzen</city>
        <zip>2625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Winkler</name>
      <address>
        <city>Bautzen</city>
        <zip>2625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Ochs</name>
      <address>
        <city>Bayreuth</city>
        <zip>95444</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Schmitt-Haendle</name>
      <address>
        <city>Bayreuth</city>
        <zip>95444</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charité Berlin Rheumatologie und Klinische Immunologie</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Med. Versorgungszentrum Ambulantes Gesundheitszentrum Charite Campus Mitte</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Hasert</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Roßbacher</name>
      <address>
        <city>Berlin</city>
        <zip>10247</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Bozorg</name>
      <address>
        <city>Berlin</city>
        <zip>10713</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Brandt-Jürgens</name>
      <address>
        <city>Berlin</city>
        <zip>12161</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Herzberg</name>
      <address>
        <city>Berlin</city>
        <zip>12435</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Remstedt</name>
      <address>
        <city>Berlin</city>
        <zip>12435</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Seifert</name>
      <address>
        <city>Berlin</city>
        <zip>12555</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Zinke</name>
      <address>
        <city>Berlin</city>
        <zip>13055</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Kors</name>
      <address>
        <city>Berlin</city>
        <zip>13086</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rheumaklinik Berlin-Buch</name>
      <address>
        <city>Berlin</city>
        <zip>13125</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Miehe</name>
      <address>
        <city>Berlin</city>
        <zip>13507</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Schnorfeil</name>
      <address>
        <city>Berlin</city>
        <zip>14163</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Koelnberger</name>
      <address>
        <city>Bogen</city>
        <zip>94327</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Barth</name>
      <address>
        <city>Borna</city>
        <zip>4552</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Eisterhues</name>
      <address>
        <city>Braunschweig</city>
        <zip>38100</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practise Ramaker-Brunke</name>
      <address>
        <city>Braunschweig</city>
        <zip>38114</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Mall</name>
      <address>
        <city>Bremen</city>
        <zip>28195</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Schwichtenberg</name>
      <address>
        <city>Bremen</city>
        <zip>28779</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practise Wagener</name>
      <address>
        <city>Bruchhausen-Vilsen</city>
        <zip>27305</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Feuchtenberger</name>
      <address>
        <city>Burghausen</city>
        <zip>84489</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Budde</name>
      <address>
        <city>Bückeburg</city>
        <zip>31675</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mvz Agliomed</name>
      <address>
        <city>Chemnitz</city>
        <zip>09130</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Schneider</name>
      <address>
        <city>Chemnitz</city>
        <zip>9116</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Geißler</name>
      <address>
        <city>Cottbus</city>
        <zip>3046</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Kirrstetter</name>
      <address>
        <city>Deggendorf</city>
        <zip>94469</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kreiskrankenhaus Demmin GmbH</name>
      <address>
        <city>Demmin</city>
        <zip>17109</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Heidlas</name>
      <address>
        <city>Dessau</city>
        <zip>6842</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Bebnowski</name>
      <address>
        <city>Dortmund</city>
        <zip>44309</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Gerlach</name>
      <address>
        <city>Dresden</city>
        <zip>1097</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Lüthke</name>
      <address>
        <city>Dresden</city>
        <zip>1097</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Fischer</name>
      <address>
        <city>Dresden</city>
        <zip>1277</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Oppers</name>
      <address>
        <city>Dresden</city>
        <zip>1277</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Roch</name>
      <address>
        <city>Dresden</city>
        <zip>1277</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Fendler</name>
      <address>
        <city>Duisburg</city>
        <zip>47057</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Riesopp</name>
      <address>
        <city>Duisburg</city>
        <zip>47249</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Strothmeyer</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40211</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bezirksklinikum Obermain</name>
      <address>
        <city>Ebensfeld</city>
        <zip>96250</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Berendt</name>
      <address>
        <city>Eberswalde</city>
        <zip>16225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Pech</name>
      <address>
        <city>Eberswalde</city>
        <zip>16225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asklepios MVZ Nord SH GmbH, c/o AK St. Georg</name>
      <address>
        <city>Elmshorn</city>
        <zip>25335</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Elbe Elster MVZ GmbH</name>
      <address>
        <city>Elsterwerda</city>
        <zip>49110</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MVZ Kaestner + Kaestner GbR</name>
      <address>
        <city>Erfurt</city>
        <zip>99096</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Koch</name>
      <address>
        <city>Erfurt</city>
        <zip>99096</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Essen, Klinik fuer Dermatologie</name>
      <address>
        <city>Essen</city>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Freitag</name>
      <address>
        <city>Falkensee</city>
        <zip>14612</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Häckel</name>
      <address>
        <city>Frankenberg</city>
        <zip>9669</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum der J.W. Goethe-Universität, Klinik für Dermatologie, Klinische Forschung</name>
      <address>
        <city>Frankfurt/Main</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Fritzsch</name>
      <address>
        <city>Frankfurt</city>
        <zip>15230</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Höhne</name>
      <address>
        <city>Fraureuth</city>
        <zip>8427</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Müller</name>
      <address>
        <city>Freiberg</city>
        <zip>9588</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Behringer</name>
      <address>
        <city>Fulda</city>
        <zip>36093</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Bussmann</name>
      <address>
        <city>Geilenkirchen</city>
        <zip>52511</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Zeh</name>
      <address>
        <city>Geislingen A.d. Steige</city>
        <zip>73312</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practice Abahji</name>
      <address>
        <city>Germering</city>
        <zip>82110</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practise</name>
      <address>
        <city>Giessen</city>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dres. Dr.Brinkmann, Schult, Samimi-Fard</name>
      <address>
        <city>Gladbeck</city>
        <zip>45964</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Kühne</name>
      <address>
        <city>Haldensleben</city>
        <zip>39340</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Liebhaber</name>
      <address>
        <city>Halle</city>
        <zip>6128</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MVZ Rheumatologie und Autoimmunmedizin GmbH</name>
      <address>
        <city>Hamburg</city>
        <zip>20095</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MVZ Nord GmbH</name>
      <address>
        <city>Hamburg</city>
        <zip>21073</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Katholisches Marienkrankenhaus Geriatrische Klinik</name>
      <address>
        <city>Hamburg</city>
        <zip>22087</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practise Höhle</name>
      <address>
        <city>Hamburg</city>
        <zip>22147</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Dahmen</name>
      <address>
        <city>Hamburg</city>
        <zip>22415</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Weinhardt</name>
      <address>
        <city>Hamburg</city>
        <zip>22523</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Aries</name>
      <address>
        <city>Hamburg</city>
        <zip>22767</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Praxis Dr. Szabo &amp; Kollegen</name>
      <address>
        <city>Hamm</city>
        <zip>59065</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practise Stille</name>
      <address>
        <city>Hannover</city>
        <zip>30161</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Stein</name>
      <address>
        <city>Hannover</city>
        <zip>30167</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Heilig</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Lassak-Siedl</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private Practise Pawlak</name>
      <address>
        <city>Heilbad Heiligenstadt</city>
        <zip>37308</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Schleußner</name>
      <address>
        <city>Heilbad Heiligenstadt</city>
        <zip>37308</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Thies</name>
      <address>
        <city>Herrsching</city>
        <zip>82211</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Meier</name>
      <address>
        <city>Hofheim</city>
        <zip>65719</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Wernicke</name>
      <address>
        <city>Hohen Neuendorf</city>
        <zip>16540</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practice Streibl</name>
      <address>
        <city>Holzkirchen</city>
        <zip>83607</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Kapelle</name>
      <address>
        <city>Hoyerswerda</city>
        <zip>2977</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Uniklinik Jena</name>
      <address>
        <city>Jena</city>
        <zip>7747</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practise Kremers</name>
      <address>
        <city>Jülich</city>
        <zip>52428</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Bräunig</name>
      <address>
        <city>Kahla</city>
        <zip>7768</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Mauer</name>
      <address>
        <city>Kamenz</city>
        <zip>1917</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practise Turin</name>
      <address>
        <city>Karlstadt</city>
        <zip>97753</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Schwab</name>
      <address>
        <city>Kiel</city>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Office of Parysa Alborz, MD</name>
      <address>
        <city>Koeln</city>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Straub</name>
      <address>
        <city>Kronach</city>
        <zip>96317</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Wilden</name>
      <address>
        <city>Köln</city>
        <zip>50825</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Merkel</name>
      <address>
        <city>Königs Wusterhausen</city>
        <zip>15711</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kreiskrankenhaus Langenau</name>
      <address>
        <city>Langenau</city>
        <zip>89129</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Boche-Hamann-Teich</name>
      <address>
        <city>Leipzig</city>
        <zip>4109</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Schwarze</name>
      <address>
        <city>Leipzig</city>
        <zip>4129</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Zeiger</name>
      <address>
        <city>Leipzig</city>
        <zip>4275</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Wiemers</name>
      <address>
        <city>Leipzig</city>
        <zip>4317</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Weiß</name>
      <address>
        <city>Lichtenstein</city>
        <zip>9350</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Holst</name>
      <address>
        <city>Ludwigslust</city>
        <zip>19288</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practise Legler</name>
      <address>
        <city>Luebeck</city>
        <zip>23564</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Kudela</name>
      <address>
        <city>Magdeburg</city>
        <zip>39104</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Raschke</name>
      <address>
        <city>Magdeburg</city>
        <zip>39104</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Sieburg</name>
      <address>
        <city>Magdeburg</city>
        <zip>39104</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Weimann</name>
      <address>
        <city>Magdeburg</city>
        <zip>39110</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hautklinik der Universitätsmedizin Mainz KöR,Clinical Research Center</name>
      <address>
        <city>Mainz</city>
        <zip>55101</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Zimmermann</name>
      <address>
        <city>Malchow</city>
        <zip>17213</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Roßbach</name>
      <address>
        <city>Mansfeld OT Großörner</city>
        <zip>06343</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Harmuth</name>
      <address>
        <city>Marktredwitz</city>
        <zip>95615</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practise Bödekker</name>
      <address>
        <city>Marl</city>
        <zip>45768</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Reck</name>
      <address>
        <city>Mittelherwigsdorf</city>
        <zip>2763</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Vollmer</name>
      <address>
        <city>Monchengladbach</city>
        <zip>41061</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stadt Klinikum Muenchen</name>
      <address>
        <city>Munchen</city>
        <zip>81925</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Krüger</name>
      <address>
        <city>München</city>
        <zip>81541</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Raub</name>
      <address>
        <city>Münster</city>
        <zip>48143</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Berger</name>
      <address>
        <city>Naunhof</city>
        <zip>4683</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Klopsch</name>
      <address>
        <city>Neubrandenburg</city>
        <zip>17033</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rheumazentrum SH Mitte GbR</name>
      <address>
        <city>Neumünster</city>
        <zip>24534</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Scholz</name>
      <address>
        <city>Neustadt-Glewe</city>
        <zip>19306</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Kloos</name>
      <address>
        <city>Neuwied</city>
        <zip>56564</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practise Hein</name>
      <address>
        <city>Nienburg</city>
        <zip>31582</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practise Vogel</name>
      <address>
        <city>Nürnberg</city>
        <zip>90482</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Albert</name>
      <address>
        <city>Offenburg</city>
        <zip>77652</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Voglau</name>
      <address>
        <city>Oldenburg</city>
        <zip>26123</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Gräßler</name>
      <address>
        <city>Pirna</city>
        <zip>1796</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Welcker</name>
      <address>
        <city>Planegg</city>
        <zip>82152</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Baumann</name>
      <address>
        <city>Plauen</city>
        <zip>8523</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practise Petersen</name>
      <address>
        <city>Potsdam</city>
        <zip>14469</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rheumahaus Potsdam GbR</name>
      <address>
        <city>Potsdam</city>
        <zip>14469</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Knappschaftskrankenhaus Püttlingen</name>
      <address>
        <city>Püttlingen</city>
        <zip>66346</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Wassenberg</name>
      <address>
        <city>Ratingen</city>
        <zip>40882</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Schwokowski</name>
      <address>
        <city>Ratzeburg</city>
        <zip>23909</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Rumpel</name>
      <address>
        <city>Regensburg</city>
        <zip>93051</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Schumann</name>
      <address>
        <city>Reken</city>
        <zip>48734</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practise Walter</name>
      <address>
        <city>Rendburg</city>
        <zip>24768</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practise Kotterik</name>
      <address>
        <city>Reutlingen</city>
        <zip>72764</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practise Hoene</name>
      <address>
        <city>Rostock</city>
        <zip>18059</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Richter</name>
      <address>
        <city>Rostock</city>
        <zip>18059</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Lankow</name>
      <address>
        <city>Rostock</city>
        <zip>18069</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Biewer</name>
      <address>
        <city>Saarbrücken</city>
        <zip>66111</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practise Mobius</name>
      <address>
        <city>Schwerin</city>
        <zip>19053</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Möbius</name>
      <address>
        <city>Schwerin</city>
        <zip>19053</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Ständer</name>
      <address>
        <city>Schwerin</city>
        <zip>19053</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Melzer</name>
      <address>
        <city>Seesen</city>
        <zip>38723</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Company for Medical Study&amp;Service Selters</name>
      <address>
        <city>Selters/Ww</city>
        <zip>56242</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practise Hoese</name>
      <address>
        <city>Stadthagen</city>
        <zip>31655</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Steinborn</name>
      <address>
        <city>Straubing</city>
        <zip>94315</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Engel</name>
      <address>
        <city>Stuttgart</city>
        <zip>70178</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ZIRS - Zentrum für Interdisziplinäre Rheumatologie Stuttgart</name>
      <address>
        <city>Stuttgart</city>
        <zip>70372</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practice Fahr</name>
      <address>
        <city>Suhl</city>
        <zip>98529</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Pyra</name>
      <address>
        <city>Torgelow</city>
        <zip>17358</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MVZ der Johanniter</name>
      <address>
        <city>Treuenbrietzen</city>
        <zip>14929</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Haas</name>
      <address>
        <city>Tübingen</city>
        <zip>72072</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practice Jacki</name>
      <address>
        <city>Tübingen</city>
        <zip>72072</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Tübingen</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Berufsausübungsgemeinschaft Dr. med Petra Roll und Dr. Margarete Kratzsch</name>
      <address>
        <city>Ulm / Donau</city>
        <zip>89073</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Rinaldi</name>
      <address>
        <city>Ulm / Donau</city>
        <zip>89073</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dres. Winkler-Gyulay, Moeller</name>
      <address>
        <city>Unna</city>
        <zip>59423</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Otte</name>
      <address>
        <city>Wesel</city>
        <zip>46483</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Schuart</name>
      <address>
        <city>Wissen/ Luhe</city>
        <zip>21423</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Metz</name>
      <address>
        <city>Wittstock</city>
        <zip>16909</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Senger</name>
      <address>
        <city>Wunstorf</city>
        <zip>31515</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikverbund St. Antonius und St. Josef GmbH, Krankenhaus St. Josef</name>
      <address>
        <city>Wuppertal</city>
        <zip>42105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practise Sprekeler</name>
      <address>
        <city>Zeven</city>
        <zip>27404</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Fricke-Wagner</name>
      <address>
        <city>Zwickau</city>
        <zip>8056</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>private practise Alliger</name>
      <address>
        <city>Zwiesel</city>
        <zip>94227</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B1801385&amp;StudyName=A%20Prospective%2C%20Multicenter%20Non-interventional%20Study%20To%20Evaluate%20The%20Efficacy%20Of%20Enbrel%20%28registered%29%20%28etanercept%29%20Over%20A%20Period%20Of%2012%20Months%20In%20The%20Routine%20Treatment%20Of%20Patients%20With%20Rheumatoid%20Arthritis%2C%20Axial%20Spondyloarthritis%2C%20Psoriatic%20Arthritis%2C%20Or%20Plaque%20Psoriasis%20With%20Particular%20Focus%20On%20The%20Clinical%20Status%20Improvements%20Still%20Observable%20After%2012%20Weeks%20Of%20Treatment</url>
    <description>To obtain contact information for a study center near you, click here.</description>
  </link>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 28, 2015</study_first_submitted>
  <study_first_submitted_qc>June 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2015</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Psoriasis</mesh_term>
    <mesh_term>Arthritis, Psoriatic</mesh_term>
    <mesh_term>Spondylarthritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Etanercept</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

